Meeting Enrollment Goals By Putting Patients First

To develop innovative therapeutics, pharmaceutical companies conduct intricate clinical trials that contend with the dual challenges of rising costs and low enrollment. Four out of five trials experience recruitment failure, which can delay trials for months with staggering daily costs of up to $8 million. Commonly, trials are postponed for up to six months due to difficulties in recruiting, enrolling, and retaining participants. Experts Lisa Kodis, clinical research lead, and Kimberly Woodson, clinical portfolio manager for Medical Research Network, explain how companies can increase enrollment while curbing unnecessary costs, including answering the following questions:

·         Is There A Solution To Enrollment Delays?

·         How Can You Maximize Patient-Centricity?

·         How Can Sponsors Run Efficient DCTs? How Can Sponsors Optimize Trial Delivery?

A patient-centric trial design that allows participants to complete a portion of the required clinical visits at home or in their community improves retention rates by reducing patient participation burden. Companies looking to increase enrollment and retention should consider ways to make their studies more patient-centered, including adopting site-centric methodologies and technology that allow participants to take part in groundbreaking clinical research on their own terms.